Quale sarebbe il prezzo per China Chemical & Pharmaceutical Co., Ltd. (1701)

Il prezzo per China Chemical & Pharmaceutical Co., Ltd. (1701) è $0.65890555

Qual è la capitalizzazione di mercato per China Chemical & Pharmaceutical Co., Ltd. (1701)

La capitalizzazione di mercato per China Chemical & Pharmaceutical Co., Ltd. (1701) è $194.28M

China Chemical & Pharmaceutical Co., Ltd. (1701) Prezzo e Capitalizzazione di Mercato

China Chemical & Pharmaceutical Co., Ltd. (CCP), established in Taipei, Taiwan, in 1952, is a prominent player in the pharmaceutical sector. The company specializes in the research, development, manufacturing, and distribution of generic pharmaceutical and healthcare products, serving both human and animal health markets. Its extensive human pharmaceutical portfolio encompasses a wide array of therapeutic areas. Key offerings include medications for cardiovascular health (such as treatments for heart conditions, cholesterol management, and peripheral circulation disorders), metabolic conditions (including diabetes, weight management, and corticosteroid therapies), and infectious diseases (like antibiotics, antifungals, and antivirals). CCP also provides a range of nutritional supplements, from vitamins and hepatic support agents to electrolyte and caloric preparations. Other significant categories cover pain and inflammation relief (antipyretics, analgesics, anti-inflammatories), digestive system remedies (gastrointestinal drugs, gut health enhancers, antispasmodics), and respiratory treatments (antitussives, antihistamines, and asthma medications). Furthermore, the company produces drugs addressing urological issues (specifically for benign prostatic hyperplasia), central nervous system disorders (hypnotics, mood stabilizers, and antidepressants), and critical areas like hematology and oncology, alongside other general preparations and sexual well-being products. Beyond prescription medications, CCP's non-prescription (OTC) division offers popular consumer health products, such as vitamins, topical skincare items, cold and cough remedies, anti-inflammatory pain relievers, and digestive aids. The company additionally supplies antibacterial and disinfectant solutions. In the animal health sector, CCP manufactures veterinary pharmaceuticals catering to livestock (pigs and cattle), poultry, and companion animals, alongside various feed supplements. Rounding out its operations, China Chemical & Pharmaceutical Co., Ltd. offers contract manufacturing services to other industry players.

Il prezzo per 1701	Attivo B	Capitalizzazione del mercato a B	Risultati
$18,396.57 $194.28M	NVDA	$5.424T	+2,791,888.99%
$16,197.49 $194.28M	AAPL	$4.776T	+2,458,142.13%
$13,741.79 $194.28M	GOOG	$4.052T	+2,085,447.27%
$12,518.21 $194.28M	MSFT	$3.691T	+1,899,749.46%
$9,307.14 $194.28M	AMZN	$2.744T	+1,412,415.60%

Il prezzo per 1701

Attivo B

Capitalizzazione del mercato a B

Risultati

$18,396.57 $194.28M